IL80678A - Human interleukin-4 - Google Patents

Human interleukin-4

Info

Publication number
IL80678A
IL80678A IL8067886A IL8067886A IL80678A IL 80678 A IL80678 A IL 80678A IL 8067886 A IL8067886 A IL 8067886A IL 8067886 A IL8067886 A IL 8067886A IL 80678 A IL80678 A IL 80678A
Authority
IL
Israel
Prior art keywords
group
cells
thr
leu
lys
Prior art date
Application number
IL8067886A
Other languages
English (en)
Other versions
IL80678A0 (en
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/843,958 external-priority patent/US5552304A/en
Priority claimed from US06/908,215 external-priority patent/US5017691A/en
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of IL80678A0 publication Critical patent/IL80678A0/xx
Publication of IL80678A publication Critical patent/IL80678A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Auxiliary Devices For Music (AREA)
  • Fertilizers (AREA)
IL8067886A 1985-11-19 1986-11-18 Human interleukin-4 IL80678A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US79966885A 1985-11-19 1985-11-19
US79966985A 1985-11-19 1985-11-19
US06/843,958 US5552304A (en) 1985-11-19 1986-03-25 CDNA Clones coding for human protein exhibiting a broad cellular activity spectrum (human interleukin-4)
US88155386A 1986-07-03 1986-07-03
US06/908,215 US5017691A (en) 1986-07-03 1986-09-17 Mammalian interleukin-4

Publications (2)

Publication Number Publication Date
IL80678A0 IL80678A0 (en) 1987-02-27
IL80678A true IL80678A (en) 1999-05-09

Family

ID=27542219

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8067886A IL80678A (en) 1985-11-19 1986-11-18 Human interleukin-4

Country Status (23)

Country Link
EP (3) EP0249613B1 (no)
JP (2) JP2557361B2 (no)
KR (1) KR940007773B1 (no)
CN (1) CN1020472C (no)
AT (2) ATE198754T1 (no)
AU (1) AU610057B2 (no)
CZ (1) CZ414191A3 (no)
DE (2) DE3650751T2 (no)
DK (1) DK371087A (no)
ES (2) ES2153444T3 (no)
FI (1) FI102075B1 (no)
GR (1) GR3021198T3 (no)
HK (2) HK1005594A1 (no)
HU (1) HU208710B (no)
IE (1) IE80828B1 (no)
IL (1) IL80678A (no)
MY (1) MY101972A (no)
NO (1) NO301234B1 (no)
NZ (1) NZ218332A (no)
OA (1) OA08947A (no)
PT (1) PT83761B (no)
SK (1) SK414191A3 (no)
WO (1) WO1987002990A1 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0740943B2 (ja) * 1985-09-30 1995-05-10 佑 本庶 新規なポリペプチドをコードするｄｎａ及びその製造方法
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US5700915A (en) * 1985-11-19 1997-12-23 Schering Corporations Human interleukin immunopurification processes
US5912136A (en) * 1985-11-19 1999-06-15 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US5082927A (en) * 1986-09-24 1992-01-21 The United States Of America As Represented By The Department Of Health And Human Services Selectively cytotoxic IL-4-PE40 fusion protein
EP0335900A4 (en) * 1986-12-19 1990-12-27 Immunex Corporation Human interleukin-4 muteins
SE8701004D0 (sv) * 1987-03-11 1987-03-11 Astra Ab Method for therapy of leukemias and certain other malignancies
WO1989001046A1 (en) * 1987-07-29 1989-02-09 Schering Biotech Corporation Purification of human interleukin-4 expressed in escherichia coli
EP0302429B1 (en) * 1987-08-03 1993-07-28 Tasuku Honjo Novel human interleukin 4, expression vectors for human interleukin 4 and transformants containing the same
JPH02485A (ja) * 1987-08-03 1990-01-05 Yuu Honshiyo 新規なヒトインターロイキン４、該因子を発現させるための組換えベクター及びそのベクターにより形質転換された形質転換体
EP0397764A1 (en) * 1988-02-02 1990-11-22 Schering Biotech Corporation Method of reducing immunoglobulin e responses
GB8808015D0 (en) 1988-04-06 1988-05-05 Ritter M A Chemical compounds
GB2218420B (en) * 1988-04-12 1992-07-15 British Bio Technology Synthetic gene encoding interleukin 4
DE68926813T2 (de) * 1988-05-13 1997-07-17 Competitive Tech Inc Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
US4958007A (en) * 1988-05-17 1990-09-18 Schering-Plough Corp. Extraction of human interleukin-4- from bacteria
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
EP0378827A1 (en) * 1988-12-21 1990-07-25 Schering Corporation Use of interleukin-4 for lowering blood glucose levels and/or effecting weight reduction
EP0454736A4 (en) * 1989-01-20 1993-05-12 The University Of Melbourne Fibrinolysis
US5077388A (en) * 1990-05-31 1991-12-31 Schering Corporation Purification of human interleukin-4 from a secreted escherichia coli mutant
CA2069090A1 (en) * 1989-11-21 1991-05-22 John A. Hamilton Anti-inflammatory compositions and methods
SE465039B (sv) * 1989-11-23 1991-07-15 Chemrec Ab Saett att framstaella koklutar med hoeg sulfiditet foer sulfatmassakokning
US5188827A (en) * 1989-12-18 1993-02-23 Schering Corporation Use of interleukin-4- for lowering blood-cholesterol levels
HU215245B (hu) 1989-12-20 1998-11-30 Schering Corp. Eljárás a humán interleukin-4 (IL-4) polipeptidek, ezekkel termelt antitestek és az antitesteket tartalmazó gyógyszerkészítmények előállítására
ZA912037B (en) * 1990-03-21 1992-03-25 Schering Corp Use of il-4 to enhance immune response to infectious antigenic challenges
CZ119993A3 (en) * 1990-12-19 1994-02-16 Schering Corp The use of il-4 for increasing immune response to immunogens in vaccines
ATE135233T1 (de) * 1991-01-10 1996-03-15 Schering Corp Verwendung von il-4 zur verstärkung von wundheilung und besserung und zur heilung von infizierten wunden und wunden bei diabetischen säugetieren
US5494662A (en) * 1992-04-27 1996-02-27 Ono Pharmaceutical Co., Ltd. Stimulator for bone formation
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents
AUPN481295A0 (en) * 1995-08-16 1995-09-07 Medvet Science Pty. Ltd. Agonists of haemopoietic growth factors
US6335426B1 (en) 1996-06-14 2002-01-01 Bayer Corporation T-cell selective interleukin-4 agonists
US5986059A (en) 1996-06-14 1999-11-16 Bayer Corporation T-cell selective interleukin-4 agonists
US6028176A (en) * 1996-07-19 2000-02-22 Bayer Corporation High-affinity interleukin-4 muteins
EP1083980B1 (en) * 1998-05-12 2007-03-21 Isis Pharmaceuticals, Inc. Modulation of molecular interaction sites on rna and other biomolecules
AUPQ005399A0 (en) * 1999-04-29 1999-05-27 Medvet Science Pty. Ltd. Agonists or antagonists for haemopoietic growth factors
SI2665486T1 (sl) 2011-01-18 2020-07-31 Bioniz, Llc Sestavki za moduliranje aktivnosti gama-C-citokina
CN102212888A (zh) * 2011-03-17 2011-10-12 靳海峰 一种基于高通量测序的免疫组库构建方法
US9959384B2 (en) 2013-12-10 2018-05-01 Bioniz, Llc Methods of developing selective peptide antagonists
US11400134B2 (en) 2015-10-09 2022-08-02 Bioniz, Llc Modulating gamma-c-cytokine activity
EP3976182A4 (en) 2019-05-03 2023-01-18 Bioniz, LLC MODULATION OF THE EFFECTS OF GAMMA CYTOKINE SIGNALING FOR THE TREATMENT OF ALOPECIA AND ALOPECIA-ASSOCIATED DISORDERS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US799668A (en) * 1905-05-29 1905-09-19 Albert R Pritchard Dough kneader and mixer.
US799669A (en) * 1905-07-27 1905-09-19 Eugene S Regnier Combined cutting and raking implement.
US843958A (en) * 1905-11-20 1907-02-12 Whitehead & Hoag Co Key-ring tag.
US4613459A (en) * 1982-10-20 1986-09-23 Dana-Farber Cancer Institute Lymphocyte growth factor
US4695542A (en) * 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
AU7082487A (en) * 1986-02-11 1987-08-25 University Of Texas System, The Recombinant human b-cell growth factor
ZA872781B (en) * 1986-05-19 1987-10-05 Immunology Ventures B-cell stimulating factor
EP0335900A4 (en) * 1986-12-19 1990-12-27 Immunex Corporation Human interleukin-4 muteins

Also Published As

Publication number Publication date
JP2568394B2 (ja) 1997-01-08
ES2153444T3 (es) 2001-03-01
DE3650751D1 (de) 2001-02-22
ATE198754T1 (de) 2001-02-15
IE80828B1 (en) 1999-03-10
EP0675136A2 (en) 1995-10-04
JP2557361B2 (ja) 1996-11-27
EP0675136A3 (en) 1996-03-13
ES2088858T3 (es) 1996-10-01
JPH0884591A (ja) 1996-04-02
DK371087D0 (da) 1987-07-16
OA08947A (en) 1990-11-30
AU6733487A (en) 1987-06-02
JPS63501401A (ja) 1988-06-02
NO872988D0 (no) 1987-07-17
DE3650538D1 (de) 1996-08-08
DK371087A (da) 1987-09-21
EP0675136B1 (en) 2001-01-17
MY101972A (en) 1992-02-29
PT83761A (en) 1986-12-01
NO872988L (no) 1987-09-18
KR940007773B1 (ko) 1994-08-25
IL80678A0 (en) 1987-02-27
DE3650751T2 (de) 2001-08-02
HU208710B (en) 1993-12-28
FI873141A (fi) 1987-07-16
IE863042L (en) 1987-05-19
NO301234B1 (no) 1997-09-29
NZ218332A (en) 1993-04-28
AU610057B2 (en) 1991-05-16
CN86108579A (zh) 1988-01-27
EP0230107A1 (en) 1987-07-29
HK1005594A1 (en) 1999-01-15
EP0249613B1 (en) 1996-07-03
SK414191A3 (en) 1995-07-11
GR3021198T3 (en) 1996-12-31
DE3650538T2 (de) 1996-12-12
HUT43630A (en) 1987-11-30
PT83761B (pt) 1989-06-30
FI102075B (fi) 1998-10-15
CZ414191A3 (en) 1993-04-14
ATE140009T1 (de) 1996-07-15
CN1020472C (zh) 1993-05-05
EP0249613A1 (en) 1987-12-23
WO1987002990A1 (en) 1987-05-21
FI102075B1 (fi) 1998-10-15
FI873141A0 (fi) 1987-07-16
HK1008823A1 (en) 1999-05-21

Similar Documents

Publication Publication Date Title
EP0675136B1 (en) Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production
US5017691A (en) Mammalian interleukin-4
Yokota et al. Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5.
FI86559C (fi) Foerfarande foer framstaellning av humant immuninterferon, daervid anvaendbara medel och dessas framstaellning.
AU626789B2 (en) Human interleukin-3 and muteins thereof
IL77080A (en) Polypeptides showing activity of human growth factor of macrophage granulocyte and eosinophils Vectors and cells transformed for their preparation and pharmaceutical preparations containing or
CA1335717C (en) Human granulocyte-macrophage colony stimulating factor and muteins thereof
US5955315A (en) Nucleic acids encoding human interleukin-4
US5104650A (en) Uses of recombinant colony stimulating factor-1
US5951973A (en) Use of interleukin-4 (IL-4) to treat rheumatoid arthritis
CA1341299C (en) Mammalian interleukin-4
US5807996A (en) Fused polypeptides comprising interleukin-4 polypeptide fragments
KR930009084B1 (ko) 포유동물의 인터로이킨-4, 이를 포함하는 조성물 및 이의 제조방법
EP0267779A2 (en) Human pleiotropic immune factor and muteins thereof
AU618143B2 (en) Cdna clones coding for polypeptides exhibiting multi- lineage cellular growth factor activity and/or mast cell growth factor activity
AU2131688A (en) Human granulocyte-macrophage colony stimulating factor and muteins thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed